Kaori Fujimoto-Ouchi

Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models

Kaori Fujimoto-Ouchi, Fumiko Sekiguchi, Hideyuki Yasuno et al. · Cancer Chemotherapy and Pharmacology · 2006 · 192 citations

Tumor Biology, Oncology, Antitumor Activity +9

Pertuzumab in Combination with Trastuzumab Shows Significantly Enhanced Antitumor Activity in HER2-Positive Human Gastric Cancer Xenograft Models

Yoriko Yamashita‐Kashima, Shigeyuki Iijima, Keigo Yorozu et al. · Clinical Cancer Research · 2011 · 176 citations · Full text

Antitumor activity of combinations of anti-HER-2 antibody trastuzumab and oral fluoropyrimidines capecitabine/5?-dFUrd in human breast cancer models

Kaori Fujimoto-Ouchi, Fumiko Sekiguchi, Yutaka Tanaka · Cancer Chemotherapy and Pharmacology · 2002 · 84 citations

Breast Oncology, Antitumor Activity, Oral Fluoropyrimidines Capecitabine/5 +10

Schedule dependency of antitumor activity in combination therapy with capecitabine/5'-deoxy-5-fluorouridine and docetaxel in breast cancer models.

Kaori Fujimoto-Ouchi, Yutaka Tanaka, Takeshi Tominaga · PubMed · 2001 · 70 citations

Medicinal Chemistry, Breast Oncology, Schedule Dependency +12

Bevacizumab improves the delivery and efficacy of paclitaxel

Mieko Yanagisawa, Keigo Yorozu, Mitsue Kurasawa et al. · Anti-Cancer Drugs · 2010 · 67 citations

Vascular Permeability, Tumor Biology, Breast Oncology +13